Contact

Organizational Design 
Consulting

Every inflection point in a MedTech company's growth requires a different organizational structure. Commercialization. Geographic expansion. Post-acquisition integration. We advise CEOs and boards on the operating model each stage demands, then place the leaders to bring it to life. Structure and talent, designed together.

The Problems We Solve

You have FDA clearance but no commercial infrastructure to reach the market.

We advise on organizational structure consulting for R&D-to-commercialization transitions, designing the functions, reporting lines, and leadership roles your product needs to generate revenue.

The Problems We Solve

A PE firm just acquired your company and the value creation thesis requires a completely different operating model.

We work with investors and post-acquisition leadership to restructure teams around commercial milestones, not legacy org charts.

The Problems We Solve

Your US market entry plan assumes you can replicate your European structure in a new regulatory environment.

We design scale-up organizational structures built around how the US market actually operates, from FDA compliance to reimbursement to field-level commercial operations.

The Problems We Solve

You have built clinical operations, regulatory affairs, and commercial teams in silos, and they are not talking to each other.

We redesign operating models so that cross-functional alignment is structural, not dependent on individual relationships.

The Problems We Solve

You have FDA clearance but no commercial infrastructure to reach the market.

We advise on organizational structure consulting for R&D-to-commercialization transitions, designing the functions, reporting lines, and leadership roles your product needs to generate revenue.

The Problems We Solve

Your US market entry plan assumes you can replicate your European structure in a new regulatory environment.

We design scale-up organizational structures built around how the US market actually operates, from FDA compliance to reimbursement to field-level commercial operations.

The Problems We Solve

A PE firm just acquired your company and the value creation thesis requires a completely different operating model.

We work with investors and post-acquisition leadership to restructure teams around commercial milestones, not legacy org charts.

The Problems We Solve

You have built clinical operations, regulatory affairs, and commercial teams in silos, and they are not talking to each other.

We redesign operating models so that cross-functional alignment is structural, not dependent on individual relationships.

Measurable Impact

Our success is measured not just in placements, but in the lasting transformation our leaders create.

logo_shape
600+MedTech transformations
driving strategic change across early-stage innovators and global market leaders
logo_shape
85%Success Rate
of our CEO placements lead successful fundraising or M&A
logo_shape
25Years of expertise
providing deep industry insights from early-stage innovators to global market leaders
logo_shape
12Successful Exits
including VisionRT, INARI Medical, and other market leaders